Spots Global Cancer Trial Database for Vaccine Therapy in Treating Patients With Malignant Melanoma
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Vaccine Therapy in Treating Patients With Malignant Melanoma
Official Title: Response of In-Transit Melanoma to Systemic Treatment With the Specific Active Immunotherapeutic Agent, Canvaxin™
Study ID: NCT00128583
Conditions
Interventions
Study Description
Brief Summary: RATIONALE: Vaccines made from tumor cells may help the body build an effective immune response to kill tumor cells. PURPOSE: This phase II trial is studying vaccine therapy to see how well it works in treating patients with malignant melanoma.
Detailed Description: OBJECTIVES: * Determine the response in patients with in-transit cutaneous malignant melanoma treated with active immunotherapy comprising polyvalent melanoma vaccine (Canvaxin™). OUTLINE: This is an open-label, multicenter study. Patients receive polyvalent melanoma vaccine (Canvaxin™) subcutaneously to the armpit and groin areas every 2 weeks for approximately 10 weeks (5 doses) and then every 4 weeks for up to approximately 1 year of total treatment (total of 15 doses). Patients with no evidence of response at week 24 receive no further treatment. Patients whose disease continues to respond after completion of study treatment are eligible for a new study in which they will continue treatment with polyvalent melanoma vaccine (Canvaxin™). After completion of study treatment, patients are followed at 30 days. PROJECTED ACCRUAL: A total of 100 patients will be accrued for this study.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Comprehensive Cancer Center at Desert Regional Medical Center, Palm Springs, California, United States
John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, California, United States
Lakeland Regional Cancer Center at Lakeland Regional Medical Center, Lakeland, Florida, United States
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa, Florida, United States
CCOP - Dayton, Dayton, Ohio, United States
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
Simmons Cancer Center at University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, United States
M.D. Anderson Cancer Center at University of Texas, Houston, Texas, United States
LDS Hospital, Salt Lake City, Utah, United States
Sydney Cancer Centre at Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
Princess Alexandra Hospital, Brisbane, Queensland, Australia
Contact Details
Name: Linda Strause
Affiliation: CancerVax Corporation
Role: STUDY_CHAIR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
